Advertisement
Screener

NIAGEN BIOSCIENCE, INC. (NAGE) Cash Flows Between Transferor and Transferee, Proceeds from New Transfers

2.5 / 5 stars · 44/89 Roast Me

NIAGEN BIOSCIENCE, INC. Cash Flows Between Transferor and Transferee, Proceeds from New Transfers

NIAGEN BIOSCIENCE, INC. (NAGE) reported Cash Flows Between Transferor and Transferee, Proceeds from New Transfers of $1.00 million for the 12-month period ending 2016-01-02, per its 10-K filed 2016-03-17.

Discontinued › Notes

us-gaap:CashFlowsBetweenTransfereeAndTransferorProceedsFromNewTransfers · last filed 2016-03-17

  • NIAGEN BIOSCIENCE, INC. cash flows between transferor and transferee, proceeds from new transfers for the quarter ending 2014-09-27 was $250.00K, a 0.00% change year-over-year.
  • NIAGEN BIOSCIENCE, INC. cash flows between transferor and transferee, proceeds from new transfers for the quarter ending 2014-06-28 was $250.00K, a 0.00% change year-over-year.
  • NIAGEN BIOSCIENCE, INC. cash flows between transferor and transferee, proceeds from new transfers for the quarter ending 2014-03-29 was $500.00K, a 0.00% change year-over-year.
  • NIAGEN BIOSCIENCE, INC. cash flows between transferor and transferee, proceeds from new transfers for the quarter ending 2013-12-28 was $0.00.
  • NIAGEN BIOSCIENCE, INC. cash flows between transferor and transferee, proceeds from new transfers for fiscal 2016 was $1.00M.
  • NIAGEN BIOSCIENCE, INC. cash flows between transferor and transferee, proceeds from new transfers for fiscal 2013 was $1.00M.
Period endCash Flows Between Transferor and Transferee, Proceeds from New Transfers 3 monthCash Flows Between Transferor and Transferee, Proceeds from New Transfers 6 monthCash Flows Between Transferor and Transferee, Proceeds from New Transfers 9 monthCash Flows Between Transferor and Transferee, Proceeds from New Transfers 12 month
2016-01-02$1.00M
10-K · filed 2016-03-17
2014-09-27$250.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06
$500.00K
derived: sum of 2 quarters · filed 2014-11-06
$1.00M
10-Q · filed 2014-11-06
$1.00M
derived: sum of 4 quarters · filed 2015-03-19
2014-06-28$250.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-12
$750.00K
10-Q · filed 2014-08-12
$750.00K
derived: sum of 3 quarters · filed 2015-03-19
$1.00M
derived: sum of 4 quarters · filed 2015-03-19
2014-03-29$500.00K
10-Q · filed 2014-05-08
$500.00K
derived: sum of 2 quarters · filed 2015-03-19
$750.00K
derived: sum of 3 quarters · filed 2015-03-19
$1.00M
derived: sum of 4 quarters · filed 2015-03-19
2013-12-28$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-19
$250.00K
derived: sum of 2 quarters · filed 2015-03-19
$500.00K
derived: sum of 3 quarters · filed 2015-03-19
$1.00M
10-K · filed 2015-03-19
2013-09-28$250.00K
derived: 10-Q 9 month − 10-Q/A 6 month · filed 2013-11-21
$500.00K
derived: sum of 2 quarters · filed 2013-12-05
$1.00M
10-Q · filed 2013-11-21
2013-06-29$250.00K
derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2013-12-05
$750.00K
10-Q/A · filed 2013-12-05
2013-03-30$500.00K
10-Q/A · filed 2013-12-05

Similar stocks

Stock NameCountryMarket CapPE Ratio
USANA HEALTH SCIENCES INC (USNA)United States$0.264B-17.90
FITLIFE BRANDS, INC. (FTLF)United States$0.087B16.59
Canopy Growth Corp (CGC)$0.395B
MANNATECH INC (MTEX)United States$0.014B
NATURAL ALTERNATIVES INTERNATIONAL INC (NAII)United States$0.011B-1.16
Synergy CHC Corp. (SNYR)United States$0.001B
Functional Brands Inc. (MEHA)United States$0.001B
Tilray Brands, Inc. (TLRY)United States$0.554B-5.97
Cronos Group Inc. (CRON)$1.223B
Definium Therapeutics, Inc. (DFTX)United States$4.931B-17.87